News

How Moderna went From pandemic hero to vaccine victim
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
STAT4d
Pharmalittle: We’re reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
Moderna (MRNA) Faces Multiple Regulatory Challenges
Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID ...
C&EN1d
US FDA approves Moderna’s next-generation COVID-19 vaccine, with caveats
The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...
Moderna Announces Update on Investigational Pandemic Influenza Program
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...